Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.7850
+0.1059 (15.59%)
At close: Oct 9, 2025, 4:00 PM EDT
0.7080
-0.0770 (-9.81%)
Pre-market: Oct 10, 2025, 5:41 AM EDT

RVPH Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
7684148874281
Upgrade
Market Cap Growth
84.29%-43.13%70.59%108.34%-48.30%182.51%
Upgrade
Enterprise Value
65.3771.29124.8868.3812.0271.92
Upgrade
Last Close Price
0.791.815.314.252.898.74
Upgrade
PE Ratio
--2.01-3.22-2.93-4.98-7.05
Upgrade
PB Ratio
-103.7525.9210.351.4514.76
Upgrade
P/TBV Ratio
-72.9373.8422.109.881.494.90
Upgrade
P/FCF Ratio
--2.51-5.23-4.58-3.91-19.84
Upgrade
P/OCF Ratio
--2.51-5.23-4.58-3.91-19.84
Upgrade
EV/EBITDA Ratio
--2.31-3.16-2.42-1.19-29.55
Upgrade
EV/EBIT Ratio
--2.31-3.16-2.42-1.19-29.54
Upgrade
EV/FCF Ratio
--2.13-4.41-3.61-1.13-17.69
Upgrade
Debt / Equity Ratio
-0.250.560000
Upgrade
Debt / EBITDA Ratio
0.00-0.01----
Upgrade
Debt / FCF Ratio
0.00-0.01----
Upgrade
Quick Ratio
0.860.921.361.8612.666.57
Upgrade
Current Ratio
0.901.011.381.9013.396.57
Upgrade
Return on Equity (ROE)
-15312.63%-916.17%-556.38%-153.19%-49.89%577.93%
Upgrade
Return on Assets (ROA)
-201.76%-157.23%-185.44%-112.10%-50.35%-55.57%
Upgrade
Return on Capital (ROIC)
-2476.56%-4823.47%--3074.07%-936.30%-159.68%
Upgrade
Return on Capital Employed (ROCE)
-11917.58%-829.38%-510.15%-148.49%-55.38%-108.58%
Upgrade
Earnings Yield
-35.85%-49.72%-31.07%-34.12%-20.07%-14.19%
Upgrade
FCF Yield
--39.79%-19.11%-21.82%-25.58%-5.04%
Upgrade
Buyback Yield / Dilution
0.00%-27.51%-22.38%-8.97%-75.75%-0.42%
Upgrade
Total Shareholder Return
--27.51%-22.38%-8.97%-75.75%-0.42%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q